Stimin G 0.5 mg/2.5 mg Injection
By Stimin G
Rx
5ml Injection in a Vial

Composition
Glycopyrrolate(0.5mg) + Neostigmine(2.5mg)

Manufacturer - Celon Laboratories Ltd
Plot No 264, Patrika Nagar Madhapur, Hitech City Hyderabad, Telangana India - 500081

Expires on or after
September, 2025

liver
Stimin G 0.5 mg/2.5 mg Injection is considered safe for use in individuals with liver disease. There is limited data available, indicating that Stimin G 0.5 mg/2.5 mg Injection may not require dose adjustments for patients with liver issues. It is important to consult your healthcare provider for personalized guidance.

kidney
Stimin G 0.5 mg/2.5 mg Injection requires caution in patients with kidney disease. Dose adjustments may be necessary. Regular monitoring of kidney function tests and blood tests is advised during treatment. Please consult your doctor for guidance.

alcohol
Stimin G 0.5 mg/2.5 mg Injection can lead to increased drowsiness when taken with alcohol. It is important to be cautious when consuming alcohol while using this medication.

driving
When using Stimin G 0.5 mg/2.5 mg Injection, be cautious while driving as it may impact your vision, coordination, and driving ability. Be aware of potential side effects that could affect your focus and reaction time on the road.

pregnancy
Stimin G 0.5 mg/2.5 mg Injection may not be safe to use during pregnancy, as animal studies have shown harmful effects on the developing baby. Your doctor will consider the benefits and risks before prescribing it. Please consult your doctor.

breastfeeding
Stimin G 0.5 mg/2.5 mg Injection is considered safe during breastfeeding with limited human data showing no significant risk to the baby. Prolonged use may decrease milk production.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹38.07
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024